miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
CONCLUSION: MiR-638 represses the characteristics and behaviors of BCSCs by targeting E2F2. MiR-638 may be a potential target for breast cancer therapy.
PMID: 31410735 [PubMed - as supplied by publisher]
Source: Breast Cancer - Category: Cancer & Oncology Authors: Lin QY, Wang JQ, Wu LL, Zheng WE, Chen PR Tags: Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Stem Cell Therapy | Stem Cells